135 related articles for article (PubMed ID: 22884281)
1. Approved medication of water with enrofloxacin to treat turkey colibacillosis: assessment of efficacy using a PK/PD approach.
Russo E; Lucatello L; Giovanardi D; Cagnardi P; Ortali G; Di Leva V; Montesissa C
Vet Microbiol; 2012 Dec; 161(1-2):206-12. PubMed ID: 22884281
[TBL] [Abstract][Full Text] [Related]
2. Enrofloxacin against Escherichia coli in turkeys: which treatment scheme is effective?
Cagnardi P; Ferraresi C; Lucatello L; Meucci V; Intorre L; Grilli G; Piccirillo A; Giacomelli M; Montesissa C
Poult Sci; 2014 Jul; 93(7):1667-74. PubMed ID: 24864295
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/pharmacodynamic evaluation of the efficacy of flumequine in treating colibacillosis in turkeys.
Ferraresi C; Lucatello L; Meucci V; Intorre L; Grilli G; Piccirillo A; Russo E; Villa R; Montesissa C; Cagnardi P
Poult Sci; 2013 Dec; 92(12):3158-65. PubMed ID: 24235225
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activities and pharmacokinetics/pharmacodynamics estimations of veterinary fluoroquinolones against avian pathogenic Escherichia coli isolates.
Ozawa M; Baba K; Shimizu Y; Asai T
Microb Drug Resist; 2010 Dec; 16(4):327-32. PubMed ID: 20624095
[TBL] [Abstract][Full Text] [Related]
6. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming.
Marien M; Decostere A; Duchateau L; Chiers K; Froyman R; Nauwynck H
Vet Microbiol; 2007 Mar; 121(1-2):94-104. PubMed ID: 17187945
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of enrofloxacin in turkeys.
Dimitrova DJ; Lashev LD; Yanev SG; Pandova B
Res Vet Sci; 2007 Jun; 82(3):392-7. PubMed ID: 17107697
[TBL] [Abstract][Full Text] [Related]
10. Effects of different types of flooring design on the development of antimicrobial resistance in commensal Escherichia coli in fattening turkeys.
Chuppava B; Keller B; Meißner J; Kietzmann M; Visscher C
Vet Microbiol; 2018 Apr; 217():18-24. PubMed ID: 29615251
[TBL] [Abstract][Full Text] [Related]
11. Effect of multiple- and single-day enrofloxacin medications against dual experimental infection with avian pneumovirus and Escherichia coli in turkeys.
Garmyn A; Martel A; Froyman R; Nauwynck H; Duchateau L; Haesebrouck F; Pasmans F
Poult Sci; 2009 Oct; 88(10):2093-100. PubMed ID: 19762861
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic properties of enrofloxacin in southern crested caracaras (Caracara plancus).
Waxman S; Prados AP; de Lucas J; San Andres MI; Sassaroli JC; Orozco M; Argibay H; Rodriguez C
J Avian Med Surg; 2013 Sep; 27(3):180-6. PubMed ID: 24344508
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of Escherichia coli strains from a turkey operation.
Altekruse SF; Elvinger F; Lee KY; Tollefson LK; Pierson EW; Eifert J; Sriranganathan N
J Am Vet Med Assoc; 2002 Aug; 221(3):411-6. PubMed ID: 12164541
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance and class 1 and 2 integrons in Escherichia coli from meat turkeys in Northern Italy.
Piccirillo A; Giovanardi D; Dotto G; Grilli G; Montesissa C; Boldrin C; Salata C; Giacomelli M
Avian Pathol; 2014; 43(5):396-405. PubMed ID: 25011666
[TBL] [Abstract][Full Text] [Related]
15. Pulse and continuous oral norfloxacin treatment of experimentally induced Escherichia coli infection in broiler chicks and turkey poults.
Sárközy G; Semjén G; Laczay P; Horváth E; Schmidt J
Acta Vet Hung; 2002; 50(2):199-210. PubMed ID: 12113175
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance pattern and virulence genes content in avian pathogenic Escherichia coli (APEC) from broiler chickens in Chitwan, Nepal.
Subedi M; Luitel H; Devkota B; Bhattarai RK; Phuyal S; Panthi P; Shrestha A; Chaudhary DK
BMC Vet Res; 2018 Mar; 14(1):113. PubMed ID: 29587768
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of gamithromycin in turkey poults with respect to Ornithobacterium rhinotracheale.
Watteyn A; Devreese M; De Baere S; Wyns H; Plessers E; Boyen F; Haesebrouck F; De Backer P; Croubels S
Poult Sci; 2015 Sep; 94(9):2066-74. PubMed ID: 26195808
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal response to the early administration of antimicrobial agents in growing turkeys infected with Escherichia coli.
Mikulski D; Juśkiewicz J; Ognik K; Fotschki B; Tykałowski B; Jankowski J
Poult Sci; 2024 Jun; 103(6):103720. PubMed ID: 38652949
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
